Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Free Market Capitalism: Laughably Predictable

On Wednesday, as the kiddies were upset over a swooning S&P, then trading a paltry 5% from the all-time high of 3,027, I tweeted out this graphic that perfectly describes my cynical view of the paper markets around the world. What prompted me to exercise my artis...
Streetwise Reports | October 8, 2019 |

Myovant Sciences Shares Rise on NDA Filing for Uterine Fibroid Combination Therapy Drug

Shares of Myovant Sciences traded 40% higher after the company reported that it has submitted a New Drug Application to the FDA for once-daily relugolix combination tablet for the treatment of women with uterine fibroids. Healthcare company Myovant Sciences Ltd. (...
Streetwise Reports | June 2, 2020 |

XPhyto: Proof of Concept for Mescalin Synthesis

It’s become a much talked-about story on both sides of the Atlantic. XPhyto Therapeutics Corp. ( CSE: XPHY ) (FSE: 4XT) (OTCQB: XPHYF) has earned considerable media coverage in recent months due to its expansion into the development of psychedelic d...
Marc Davis | June 9, 2021 |

No time like the present for Goldshore Resources

Goldshore Resources (GSHR) is a junior gold development company that is tri-listed and is also relatively new. Trading here in Canada the company occupies the Venture Exchange. The company has managed to stay well-financed and is supported by a strong management group. ...
Brieanna McCutcheon | May 31, 2023 |

Can the Oil Bulls Succeed in Their Comeback Attempt After Yesterday’s Slide?

After several days of relative hesitation, oil did finally moved through and closed below an important support level, making our position immediately profitable. Can the bulls however mount a strong enough response to invalidate the breakdown? So far, it doesn’...
Przemyslaw Radomski, CFA | October 1, 2019 |

Aquestive Therapeutics Shares Up on Pipeline Update and Raised Full-Year 2019 Guidance

Aquestive Therapeutics shares traded 20% higher today after the firm reported Q3/19 earnings and raised its FY/19 guidance. The firm states it expects to complete its NDA for Libervant buccal film near the end of this month. Yesterday afternoon, specialty pharmaceutic...
Streetwise Reports | November 7, 2019 |

Coverage Initiated on Energy Efficiency Firm, 'One of a Kind Stock'

The thesis for investing in this company is provided in a Raymond James report. In a Nov. 21 research note, analyst Pavel Molchanov reported that Raymond James initiated coverage on Ameresco Inc. (AMRC:NYSE) with a Strong Buy rating and a $20 per share target price....
Streetwise Reports | December 2, 2019 |

vTv Therapeutics' Shares open 80% Higher on Phase 2 Type 1 Diabetes Trial Data

Shares of vTv Therapeutics traded 50% higher after the company reported positive results from Part 2 of the Phase 2 Simplici-T1 Study of TTP399 used in the treatment of patients with type 1 diabetes. Clinical-stage pharmaceutical company focused on treating ...
Streetwise Reports | February 11, 2020 |

Grande Portage Resources Strikes Gold

Bob Moriarty of 321gold profiles an exploration junior with a high-grade project in the Juneau gold belt. There are a ton of tiny juniors out there who are taking advantage of a more favorable financing market to cash up and get cranking. One, with a tiny ma...
Streetwise Reports | February 18, 2020 |

Dolly Varden Silver Is Going to Ride Again

As I write the ratio of silver to gold is about 96-1. It takes 96 ounces of silver to buy one ounce of gold. As the magnificent Steve Saville has just pointed out the ratio is within five percent of the highest it has ever been in history. Once in 1942 and again in 1993...
Streetwise Reports | March 3, 2020 |
1 2 3 4